Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers.
about
Neridronic acid for the treatment of bone metabolic diseases.Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study.
P2860
Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Single infusion of neridronate ...... y and bone resorption markers.
@en
Single infusion of neridronate ...... y and bone resorption markers.
@nl
type
label
Single infusion of neridronate ...... y and bone resorption markers.
@en
Single infusion of neridronate ...... y and bone resorption markers.
@nl
prefLabel
Single infusion of neridronate ...... y and bone resorption markers.
@en
Single infusion of neridronate ...... y and bone resorption markers.
@nl
P2093
P2860
P356
P1476
Single infusion of neridronate ...... y and bone resorption markers.
@en
P2093
Marco Bulleri
Maria Rita Metelli
Maurizio Mazzantini
Ombretta Di Munno
Roberto Giordani
P2860
P2888
P304
P356
10.1007/BF03324436
P577
2002-06-01T00:00:00Z